WEE1 Gene
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">WEE1 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>WEE1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>WEE1</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=WEE1" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/colorectal-cancer" style="color:#ef9a9a">Colorectal Cancer</a>, <a href="/wiki/tumor" style="color:#ef9a9a">Tumor</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">14 edges</a></td>
</tr>
</table>
WEE1 is a nuclear tyrosine kinase that serves as a critical cell cycle checkpoint protein, primarily known for its role in inhibiting CDK1 (cdc2) to prevent premature mitotic entry[@wee2021]. As the sole kinase responsible for the inhibitory Y15 phosphorylation on CDK1 in mammals, WEE1 acts as a fundamental safeguard against unscheduled cell division. Beyond its canonical cell cycle functions, WEE1 has emerged as an important player in DNA damage response and has been implicated in neuroprotective mechanisms that may be relevant to neurodegenerative diseases[@wee2022a].
...
WEE1 Gene
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">WEE1 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>WEE1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>WEE1</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=WEE1" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/colorectal-cancer" style="color:#ef9a9a">Colorectal Cancer</a>, <a href="/wiki/tumor" style="color:#ef9a9a">Tumor</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">14 edges</a></td>
</tr>
</table>
WEE1 is a nuclear tyrosine kinase that serves as a critical cell cycle checkpoint protein, primarily known for its role in inhibiting CDK1 (cdc2) to prevent premature mitotic entry[@wee2021]. As the sole kinase responsible for the inhibitory Y15 phosphorylation on CDK1 in mammals, WEE1 acts as a fundamental safeguard against unscheduled cell division. Beyond its canonical cell cycle functions, WEE1 has emerged as an important player in DNA damage response and has been implicated in neuroprotective mechanisms that may be relevant to neurodegenerative diseases[@wee2022a].
The WEE1 protein is evolutionarily conserved from yeast to humans, reflecting its essential role in cell cycle control. In humans, WEE1 is expressed ubiquitously with particularly important functions in rapidly dividing cells and in tissues requiring DNA damage protection[@kornbluth2012].
Gene Structure and Expression
The human WEE1 gene is located on chromosome 11p15.4 and encodes a protein of 646 amino acids with a molecular weight of approximately 70 kDa. The gene contains multiple exons and is transcribed into multiple mRNA variants.
Tissue Distribution
WEE1 exhibits broad tissue distribution:
- Proliferating cells: High expression in dividing cells
- Brain: Moderate expression in neurons and glia
- Development: High expression during embryonic development
- Adult tissues: Variable expression across different organs
Subcellular Localization
WEE1 localizes primarily to:
- Nucleus: Main site of function
- Cytoplasm: Some inactive pool
- Chromatin: Direct interaction with DNA
Protein Function and Mechanism
Catalytic Activity
WEE1 is a protein kinase that specifically phosphorylates:
CDK1 (cdc2): Primary substrate at Y15
CDK2: Secondary target at Y15
Other substrates: Less characterizedThe phosphorylation at Y15 maintains CDK1 in an inactive state until proper mitotic entry conditions are met.
Cell Cycle Regulation
WEE1 functions at the G2/M checkpoint:
- G2 arrest: Prevents premature mitosis
- DNA damage response: Halts cell cycle for repair
- S-phase checkpoint: Prevents replication stress
- Mitotic entry control: Ensures proper timing
Regulation
WEE1 activity is modulated by:
Phosphorylation: Autophosphorylation and regulatory kinases
Protein degradation: Ubiquitin-mediated turnover
Transcriptional control: Cell cycle-dependent expression
Subcellular localization: Nuclear import/exportRole in Neurodegeneration
DNA Damage Response
WEE1 plays crucial roles in neuronal DNA damage protection:
Checkpoint activation: Prevents cell division in damaged neurons
DNA repair coordination: Links damage sensing to cell cycle arrest
Apoptosis prevention: Allows time for repair or recoveryAlzheimer's Disease
WEE1 involvement in AD includes:
- Cell cycle dysregulation: Abnormal checkpoint control
- DNA damage accumulation: Impaired repair mechanisms
- Neuronal vulnerability: Loss of protective mechanisms
Parkinson's Disease
In PD, WEE1 may contribute through:
- Dopaminergic neuron survival: DNA damage protection
- Mitochondrial dysfunction: Links to energy metabolism
- Alpha-synuclein pathology: Possible interactions
Therapeutic Potential
WEE1 as a therapeutic target:
Inhibition strategies: Using WEE1 inhibitors in cancer therapy
Protection approaches: Enhancing WEE1 function in neurodegeneration
Combination therapies: With other neuroprotective agentsClinical Significance
Cancer
WEE1 is a validated cancer target:
- Overexpression: Common in various tumors
- Therapeutic inhibition: WEE1 inhibitors in clinical trials
- Combination strategies: With DNA-damaging agents
Neurological Disease
While still being characterized:
- Protective roles: DNA damage protection in neurons
- Dysfunction implications: Contribution to neurodegeneration
- Therapeutic targeting: Potential for neuroprotection
Signaling Pathways
Mermaid diagram (expand to render)
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Cell Cycle Checkpoints](/mechanisms/cell-cycle-checkpoints)
- [DNA Damage Response](/mechanisms/dna-damage-response)
- [CDK1](/proteins/cdk1-protein)
References
[Matheson et al., Targeting WEE1 kinase in cancer and beyond (2016)](https://pubmed.ncbi.nlm.nih.gov/27207624/)
[Tobias et al., WEE1 in DNA damage response and cancer therapy (2019)](https://pubmed.ncbi.nlm.nih.gov/31037457/)
[WEE1 kinase in cell cycle regulation (2021)](https://doi.org/10.1016/j.tcb.2021.04.007)
[WEE1 inhibition in cancer therapy (2022)](https://doi.org/10.1038/s41571-022-00635-1)
[DNA damage response in neurodegeneration (2023)](https://doi.org/10.1007/s12035-023-03245-5)
[Cell cycle re-entry in Alzheimer's disease (2021)](https://doi.org/10.1016/j.neurobiolaging.2020.10.015)
[WEE1 as therapeutic target in neurodegeneration (2022)](https://doi.org/10.1007/s12035-022-03112-7)
[Kastan et al., A mammalian cell cycle checkpoint utilizing p53 and GADD45 is defective in ataxia-telangiectasia (1991)](https://pubmed.ncbi.nlm.nih.gov/1840700/)
[Raleigh & O'Connell, DNA damage checkpoint maintenance (2000)](https://pubmed.ncbi.nlm.nih.gov/10671371/)
[Kornbluth et al., WEE1 kinase as a therapeutic target in cancer (2012)](https://pubmed.ncbi.nlm.nih.gov/22594506/)
[Haines et al., Cell cycle regulation in neurodegeneration (2011)](https://pubmed.ncbi.nlm.nih.gov/21595658/)
[Koppen et al., WEE1 kinase: functions in cell cycle and DNA damage response (2015)](https://pubmed.ncbi.nlm.nih.gov/26709806/)
[Gordon et al., Cell cycle proteins in brain aging and neurodegeneration (2011)](https://pubmed.ncbi.nlm.nih.gov/21844062/)
[Zhou et al., Role of WEE1 in neuronal development and function (2000)](https://pubmed.ncbi.nlm.nih.gov/10817930/)
[Mueller et al., WEE1 inhibition in pediatric brain tumors (2012)](https://pubmed.ncbi.nlm.nih.gov/22261806/)
[Leung et al., WEE1 regulates synaptic plasticity and memory formation (2019)](https://pubmed.ncbi.nlm.nih.gov/31043567/)
[Chen et al., WEE1 in neuronal survival after DNA damage (2021)](https://pubmed.ncbi.nlm.nih.gov/34011942/)
[Rothblum et al., WEE1 kinase: potential therapeutic target in neurodegeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/31182289/)External Links
- [NCBI Gene: WEE1](https://www.ncbi.nlm.nih.gov/gene/7465)
- [Ensembl: ENSG00000166401](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000166401)
- [UniProt: P30291](https://www.uniprot.org/uniprot/P30291)
- [OMIM: 193500](https://www.omim.org/entry/193500)
Additional Functions
Synaptic Plasticity
WEE1 has been implicated in synaptic function:
- Memory formation: Required for proper synaptic plasticity
- Long-term potentiation: Links to learning and memory
- Synaptic scaling: Activity-dependent adjustments
Neuronal Development
During brain development, WEE1 plays roles in:
- Cell cycle control: During neurogenesis
- Migration: Neuronal positioning
- Differentiation: Fate determination
Summary
WEE1 is a critical cell cycle kinase that prevents premature mitotic entry through CDK1 inhibition. While primarily studied in the context of cancer biology, WEE1 also plays important roles in protecting neurons from DNA damage and maintaining genomic integrity. Its involvement in DNA damage response and checkpoint control makes it relevant to understanding neurodegenerative processes in conditions such as Alzheimer's disease and Parkinson's disease. The dual nature of WEE1—as both a potential therapeutic target in cancer and a neuroprotective factor in neurodegeneration—highlights the complexity of cell cycle regulation in different cellular contexts.
Pathway Diagram
The following diagram shows the key molecular relationships involving WEE1 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)